Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine.
D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002648:Child; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007279:Injections, Subcutaneous; D008457:Measles / Q000276:immunology*; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D008722:Methods; D009666:Nose; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D012412:Rubella virus; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage*
D000906:Antibodies; D008458:Measles Vaccine; D012411:Rubella Vaccine; D014765:Viral Vaccines